title: Prospective randomized study comparing FK 506 (Prograft) and cyclosporine A (Neoral) as primary immunosuppression in cadaveric renal transplants at a single institution: interim report of the first 80 cases.
authors.affiliation: Department of Transplant Surgery, University of Wales Healthcare NHS Trust, Cardiff, United Kingdom.
authors.forename: G
authors.initials: G
authors.lastname: Morris-Stiff
authors.forename: J
authors.initials: J
authors.lastname: Singh
authors.forename: K
authors.initials: K
authors.lastname: Ostrowski
authors.forename: V
authors.initials: V
authors.lastname: Balaji
authors.forename: R
authors.initials: R
authors.lastname: Moore
authors.forename: C
authors.initials: C
authors.lastname: Darby
authors.forename: R
authors.initials: R
authors.lastname: Lord
authors.forename: W A
authors.initials: WA
authors.lastname: Jurewicz
mesh_terms: D000328:Adult; D002102:Cadaver; D016572:Cyclosporine / Q000009:adverse effects / Q000627:therapeutic use*; D004359:Drug Therapy, Combination; D005500:Follow-Up Studies; D006084:Graft Rejection / Q000453:epidemiology; D006801:Humans; D007166:Immunosuppressive Agents / Q000009:adverse effects / Q000627:therapeutic use*; D016030:Kidney Transplantation / Q000276:immunology*; D008875:Middle Aged; D011446:Prospective Studies; D016559:Tacrolimus / Q000009:adverse effects / Q000627:therapeutic use*; D013997:Time Factors; D014019:Tissue Donors
chemical_list: D007166:Immunosuppressive Agents; D016572:Cyclosporine; D016559:Tacrolimus